These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7334719)

  • 61. [Ig synthesis of lymphocytes from idiopathic nephrotic syndrome patients (author's transl)].
    Kumon S; Okura T; Hibi I; Matsuo S; Tamaki S; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1981 Oct; 23(10):1291-34. PubMed ID: 7334714
    [No Abstract]   [Full Text] [Related]  

  • 62. Cyclophosphamide and the nephrotic syndrome.
    Drummond KN
    Br Med J; 1969 May; 2(5656):576-7. PubMed ID: 5769897
    [No Abstract]   [Full Text] [Related]  

  • 63. Cyclophosphamide in minimal-change nephrotic syndrome.
    Rizvi SN; Vaishnava H
    Lancet; 1972 Jul; 2(7770):229. PubMed ID: 4114232
    [No Abstract]   [Full Text] [Related]  

  • 64. Cyclophosphamide in adult-onset nephrotic syndrome.
    Cameron JS; Ogg CS
    Lancet; 1972 Jun; 1(7765):1397-8. PubMed ID: 4113604
    [No Abstract]   [Full Text] [Related]  

  • 65. [A study on the side effect of longstanding steroid therapy: lessening of the side effects by giving steroid on consecutive three or four days a week (author's transl)].
    Miura K; Tomioka Y; Fushimi K; Nagai K; Takahashi H
    Horumon To Rinsho; 1979 Oct; 27(10):1141-57. PubMed ID: 116783
    [No Abstract]   [Full Text] [Related]  

  • 66. Letter: Hyperpigmentation after cancer chemotherapy.
    Lancet; 1975 Jul; 2(7925):128. PubMed ID: 49718
    [No Abstract]   [Full Text] [Related]  

  • 67. Cyclophosphamide and the prepubertal testis.
    Arneil GC
    Lancet; 1972 Dec; 2(7789):1259-60. PubMed ID: 4117757
    [No Abstract]   [Full Text] [Related]  

  • 68. Cyclophosphamide and infertility.
    Feng PH; George CR; Evans RA; Murkin GE; Spicer E; Thomas BS; Hellmann K; Hassib H; Hassib F
    Lancet; 1972 Apr; 1(7755):840-2. PubMed ID: 4111595
    [No Abstract]   [Full Text] [Related]  

  • 69. Prepubertal cyclophosphamide therapy and gonadal dysfunction: a case report and review of the literature.
    Alfiler CA
    Aust Paediatr J; 1979 Jun; 15(2):120-3. PubMed ID: 485993
    [No Abstract]   [Full Text] [Related]  

  • 70. Letter: Cyclophosphamide and neoplasia.
    Wood L
    Lancet; 1974 Oct; 2(7885):898-9. PubMed ID: 4137763
    [No Abstract]   [Full Text] [Related]  

  • 71. Cellular immunity and nephrotic syndrome.
    Menchaca JA
    J Pediatr; 1980 Sep; 97(3):508-9. PubMed ID: 6967967
    [No Abstract]   [Full Text] [Related]  

  • 72. Hyperlipoproteinaemia, cellular immunity, and nephrotic syndrome.
    Menchaca JA; Lefkowitz S
    Lancet; 1980 May; 1(8177):1084-5. PubMed ID: 6103416
    [No Abstract]   [Full Text] [Related]  

  • 73. Cyclophosphamide therapy for neprosis.
    Etteldorf JN
    J Pediatr; 1968 Oct; 73(4):641. PubMed ID: 5678006
    [No Abstract]   [Full Text] [Related]  

  • 74. [TREATMENT OF NEPHROTIC SYNDROMES WITH AN ANTIMITOTIC AGENT].
    RIFFAT G; POTTON F
    J Med Lyon; 1963 Apr; 44():727-39. PubMed ID: 14076448
    [No Abstract]   [Full Text] [Related]  

  • 75. Author's reply.
    Mantan M
    Saudi J Kidney Dis Transpl; 2020; 31(2):562. PubMed ID: 32394938
    [No Abstract]   [Full Text] [Related]  

  • 76. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
    Okura T; Matsuo S; Kumon S; Hibi I; Tamaki S; Watanabe Y; Kinoshita Y
    Nihon Jinzo Gakkai Shi; 1981 Nov; 23(11):1395-403. PubMed ID: 7334719
    [No Abstract]   [Full Text] [Related]  

  • 77. [The cyclophosphamide treatment of glomerulonephritis patients].
    Dorets'kyĭ VV
    Vrach Delo; 1991 Feb; (2):51-3. PubMed ID: 2058123
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 79. [Cell mediated immunity in a mercury nephrotic syndrome (author's transl)].
    Normand M; Cayotte JL; Chouraqui D; Fizet D
    Sem Hop; 1982 May; 58(19):1185-7. PubMed ID: 6285502
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immune abnormality in primary nephrotic syndrome--a study of cell mediated immunity with special reference to suppressor cell (author's transl)].
    Hibi I; Okura T; Kumon S; Matsuo S; Tamaki S; Sakamoto N
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1067-86. PubMed ID: 6459475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.